NCT07563569

Brief Summary

compare the impact of type of anesthesia on ERCP including technical success, rate of complications, peri procedural safety, patient and endoscopist satisfaction in adult patients with obstructive jaundice

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started May 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 4, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

May 20, 2026

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2026

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2027

Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

April 17, 2026

Last Update Submit

April 25, 2026

Conditions

Keywords

ERCP

Outcome Measures

Primary Outcomes (1)

  • Impact of type of anesthesia on technical success rate

    Technical success rate defined as successful deep biliary cannulation and completion of the intended therapeutic intervention.

    at the time of the procedure

Secondary Outcomes (1)

  • rate of procedure related complications

    at the time of procedure up to 72 hours post procedure

Study Arms (2)

Group A

EXPERIMENTAL

50 patient will under go procedure (ERCP) under general anesthesia (25 calcular obstructive jaundice ,25 malignant obstructive jaundice)

Procedure: ERCP

Group B

EXPERIMENTAL

50 patient will under go procedure (ERCP)under sedation (25 calcular obstructive jaundice, 25 malignant obstructive jaundice)

Procedure: ERCP

Interventions

ERCPPROCEDURE

Effect of anesthesia on Therapeutic ERCP in patients obstructive jaundice

Group AGroup B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients above 18 years old.
  • Patient with obstructive jaundice as an indication for therapeutic ERCP.
  • Provided written informed consent.

You may not qualify if:

  • Patients below 18 years old.
  • Indications for ERCP other than obstructive jaundice.
  • with coagulopathy not corrected prior to procedure.
  • severe active cardiopulmonary comorbidities.
  • Previous altered upper GIT anatomy (e.g gastric by-pass).
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Jaundice, Obstructive

Interventions

Cholangiopancreatography, Endoscopic Retrograde

Condition Hierarchy (Ancestors)

JaundiceHyperbilirubinemiaPathologic ProcessesPathological Conditions, Signs and SymptomsSkin ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

CholangiographyRadiography, AbdominalRadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, Digestive SystemEndoscopy, Digestive SystemEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Mohamed Khaled Abd El-Azeem

    Tropical medicine and Gastroentrology department

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mohamed Khaled Abd El-Azeem

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor, Tropical Medicine and Gastroentrology

Study Record Dates

First Submitted

April 17, 2026

First Posted

May 4, 2026

Study Start (Estimated)

May 20, 2026

Primary Completion (Estimated)

November 20, 2026

Study Completion (Estimated)

May 20, 2027

Last Updated

May 4, 2026

Record last verified: 2026-04